Previous use of CM for noncancer-related outcomes was found to be predictive of patient adherence to a CM treatment regimen provided within conventional oncology service.

Context and objectives The present study examined the perspectives of healthcare providers (HCPs) in designing a multi-disciplinary model of supportive cancer care for the relief of dermatology-related symptoms caused by monoclonal antibody therapies. Methods The study employed a mixed research methodology, with qualitative research embedded within a pragmatic prospective study of a registry protocol study. Patients undergoing oncology therapy with MoAB, anti-HER2, and anti-PD-L1 monoclonal antibodies were identified among a cohort of patients referred to an integrative oncology (IO) consultation for symptom relief and improved quality of life (QoL). Case studies with significant dermatology-related concerns were selected and presented to a panel of 6 HCPs trained in medical oncology, oncology nursing, family medicine, supportive cancer care, and IO. HCP narratives were qualitatively analyzed and assessed using ATLAS.Ti software for systematic coding. Results Of the 924 patients referred to the IO consultation, 208 were treated with monoclonal antibodies, from which 50 were selected for further evaluation. Of these, 7 cases were presented to the HCP team who were asked to identify treatment gaps requiring a multi-disciplinary approach. Qualitative analysis identified 3 major themes: a biophysical perspective; a psycho-social-spiritual perspective; and the implementation of integrated care. Discussion There is a need for a multi-disciplinary approach when treating patients suffering from monoclonal antibody treatment-related skin toxicities. HCP-reported themes highlight the need to identify patients for whom such an approach is warranted; conditions in which a psycho-social-spiritual perspective should be considered, in addition to a bio-physical approach; and considerations of who should be designated as the patient’s primary case manager.

Context and objectives: The present study examined the perspectives of healthcare providers (HCPs) in designing a multi-disciplinary model of supportive cancer care for the relief of dermatology-related symptoms caused by immunotherapy. Methods: This qualitative study identified patients undergoing oncology therapy with MoAB, anti-HER2 and anti-PD-L1 monoclonal antibodies among a cohort of patients referred to an integrative oncology (IO) consultation for symptom relief and improved quality of life (QoL). Case-studies with significant dermatology-related concerns were selected and presented to a panel of 6 HCPs trained in medical oncology, oncology nursing, family medicine, supportive cancer care and IO. HCP narratives were qualitatively analyzed and assessed using ATLAS.Ti software for systematic coding. Results: Of 924 patients referred to the IO consultation, 208 were treated with immunotherapy, from which 50 were selected for further evaluation. Of these, and 7 cases were presented to the HCP team which then identified treatment gaps requiring a multi-disciplinary approach. Qualitative analysis identified 3 major themes: a biophysical perspective; a psycho-social-spiritual perspective; and the implementation of integrated care. Discussion: There is a need for a multi-disciplinary approach when treating patients suffering from immunotherpay-related skin toxicities. HCP-reported themes highlight the need to identify patients where such an approach is warranted; conditions where a psycho-social-spiritual perspective should be considered in addition to the bio-physical approach; and considerations of who should be appointed as the patient’s case manager.

As editor-in-chief of Diabetes Spectrum, I often ask friends and colleagues to consider submitting their clinical work for publication. Most often, the responses I hear from those individuals deep in the trenches of diabetes care are, "I don't like to write," or "I cannot write." Yet these are the same people who participate in the everyday care and education of people with diabetes. It is through their clinical expertise that we all learn to be better educators and providers of diabetes care. Over the past several months, many excellent articles were submitted for publication to Diabetes Spectrum. In an effort to publish as many of these articles as possible, for this issue only we have chosen to publish five feature articles on a variety of topics instead of our usual From Research to Practice section. We hope that you enjoy reading these articles and agree that, every once in a while, it is important to deviate from the usual.